AccScience Publishing / JCBP / Volume 4 / Issue 2 / DOI: 10.36922/JCBP026030003
Submit to JCBP
Cite this article
23
Download
432
Views
Journal Browser
Volume | Year
Issue
Search
Forthcoming Issue
Current Issue
View All
News and Announcements
View All
REVIEW ARTICLE

Expert consensus on the clinical application of Tianmeng oral liquid in psychosomatic disorders

Zhenghua Hou1 ,  Leyi Zhang2 ,  Sizhi Ai3 ,  Maosheng Fang4 ,  Rongjuan Guo5 ,  Manli Huang6 ,  Wenjing Jiang7 ,  Xiuli Li8 ,  Jin Liu9 ,  Ping Liu10 ,  Xiangzhe Liu11 ,  Dongsheng Lv12 ,  Lijun Qiao13 ,  Qinji Su14 ,  Lu Sun15 ,  Jiong Tao16 ,  Jing Teng17 ,  Han Wang18 ,  Chuansheng Wang19 ,  Huaning Wang20 ,  Peng Xiong21 ,  Fengquan Xu22 ,  Zhenghui Yi4 ,  Jie Zhang23 ,  Yupeng Zhang24 ,  Min Zhao11 ,  Peng Zhao25 ,  Yuehan Zhao26 ,  Bo Zhou27 ,  Shaohong Zou28 ,  Wei Zou29 ,  Wenbin Guo2* ,  Yonggui Yuan1*
Show Less
1 Department of Psychosomatic Medicine, Zhongda Hospital, Southeast University, Nanjing, Jiangsu, China
2 Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China
3 Centre for Sleep and Circadian Medicine, The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, Guangdong, Chin
4 Clinical Department 7, Shanghai Mental Health Center, Shanghai, China
5 Department of Psychosomatic Medicine, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China
6 Department of Psychiatry, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
7 Department of Geriatric Medicine, Qilu Hospital of Shandong University, Jinan, Shandong, China
8 Department of Clinical Psychology, Yidu Central Hospital, Weifang, Shandong, China
9 Department of Neurology, Tianjin Prevention and Treatment Center for Occupational Diseases, Tianjin, China
10 Department of Cardiology, The Qilu Second Hospital of Shandong University, Jinan, Shandong, China
11 Department of Encephalopathy, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan, China
12 Department of Psychiatry, Inner Mongolia Autonomous Region Brain Hospital (Mental Health Center), Inner Mongolia, China
13 Department of Neurology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China
14 Department of Mental Health, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China
15 Department of Psychosomatic Diseases, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China
16 Department of Psychiatry, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
17 Department of Neurology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China
18 Encephalopathy Center, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui, China
19 Department of Psychiatry, The Second Affiliated Hospital of Henan Medicine University, Zhengzhou, Henan, China
20 Department of Psychosomatic Medicine, Xijing Hospital, Xi’an, Shaanxi, China
21 Department of Psychiatry, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China
22 Department of Psychosomatic Medicine, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China
23 Department of Psychosomatic Medicine, Beijing Hospital of Traditional Chinese Medicine affiliated to Capital Medical University, Beijing, China
24 Department of Clinical Psychology, Changchun Sixth Hospital, Changchun, Jilin, China
25 Department of Cardiology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China
26 Department of Clinical Psychology, Weifang People’s Hospital, Weifang, Shandong, China
27 Sichuan Provincial Center for Mental Health, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China
28 Department of Clinical Psychology, People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China
29 Department of Acupuncture and Moxibustion, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China
JCBP 2026, 4(2), 026030003 https://doi.org/10.36922/JCBP026030003
Received: 14 January 2026 | Revised: 30 January 2026 | Accepted: 13 February 2026 | Published online: 31 March 2026
© 2026 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Download PDF
XML
Cite
Abstract

Psychosomatic disorders are characterized by complex interactions between psychological factors and somatic symptoms and frequently present with comorbid insomnia, anxiety, and depressive symptoms. Although conventional pharmacological treatments are widely used, their limitations highlight the need for integrative therapeutic approaches. Tianmeng oral liquid, a multi-component Chinese herbal formulation, has been increasingly used in clinical practice for the treatment of psychosomatic symptoms. This review aims to develop expert consensus on the clinical application of Tianmeng oral liquid in the treatment of psychosomatic disorders. This consensus was developed through a comprehensive review of the literature, evaluation of available clinical and experimental evidence, and structured expert panel discussions. Recommendations were formulated based on evidence strength, clinical experience, and principles of psychosomatic medicine. Tianmeng oral liquid exhibits a multi-target pharmacological profile, modulating central nervous system activity, neuroendocrine regulation, and immune homeostasis. Available evidence suggests that it may improve sleep quality, alleviate anxiety and depressive symptoms, and enhance overall well-being in patients with psychosomatic disorders. The formulation may be used as monotherapy in mild cases or as an adjunct to standard pharmacological and psychological interventions. It is generally well tolerated when administered according to recommended dosing strategies. Tianmeng oral liquid may be considered a complementary therapeutic option within a comprehensive biopsychosocial treatment framework for psychosomatic disorders. Further high-quality randomized controlled trials and mechanistic studies are warranted to strengthen the evidence base and refine clinical application strategies.

Keywords
Psychosomatic disorders
Insomnia
Tianmeng oral liquid
Integrative medicine
Chinese herbal compound
Funding
None.
Conflict of interest
Bo Zhou, Shaohong Zou, and Wenbin Guo are the Editorial Board Members of this journal, but were not in any way involved in the editorial and peer-review process conducted for this paper, directly or indirectly. Separately, other authors declared that they have no known competing financial interests or personal relationships that could have influenced the work reported in this paper.
References
  1. Jantschek G, Rodewig K, Von Wietersheim J, et al. Concepts of psychosomatic disorders in ICD-10: results of the Research Criteria Study. Psychother Psychosom. 1995;63(2):112-123. doi: 10.1159/000288947
  2. Kellner R. Psychosomatic syndromes, somatization and somatoform disorders. Psychother Psychosom. 1994; 61(1- 2):4-24. doi: 10.1159/000288868
  3. Fava GA, Cosci F, Sonino N. Current Psychosomatic Practice . Psychother Psychosom. 2017;86(1):13-30. doi: 10.1159/000448856
  4. Lask B. “Psychosomatic medicine” not “psychosomatic disorders”. J Psychosom Res. 1996;40(5):457-460. doi: 10.1016/0022-3999(95)00578-1
  5. Chandrashekar CR, Math SB. Psychosomatic disorders in developing countries: current issues and future challenges. Curr Opin Psychiatry. 2006;19(2):201-206. doi: 10.1097/01.yco.0000214349.46411.6a
  6. Ma N, Pan B, Yang S, et al. Comparative efficacy and safety of Chinese patent medicines for primary insomnia: A systematic review and network meta-analysis of 109 randomized trials. J Ethnopharmacol. 2025;340:119254. doi: 10.1016/j.jep.2024.119254
  7. Fava G A, Sonino N. Psychosomatic assessment. Psychother Psychosom. 2009;78(6):333-41. doi: 10.1159/000235736
  8. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA. 1999;282(18):1737-1744. doi: 10.1001/jama.282.18.1737
  9. Lowe B, Decker O, Muller S, et al. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med Care. 2008;46(3):266-274. doi: 10.1097/MLR.0b013e318160d093
  10. Kroenke K, Spitzer R L, Williams J B. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med. 2002;64(2):258-66. doi: 10.1097/00006842-200203000-00008
  11. Li L, Peng T, Liu R, et al. Development of the psychosomatic symptom scale (PSSS) and assessment of its reliability and validity in general hospital patients in China. Gen Hosp Psychiatry. 2020;64:1-8. doi: 10.1016/j.genhosppsych.2020.01.008
  12. Liu XY. Establishment of Fingerprint of Tianmeng Oral Liquid and Efficacy-related Components Study. [Dissertation] Shandong University. 2020. [In Chinese] doi: 10.27272/d.cnki.gshdu.2020.005146
  13. Zhang DX, Sun WX, Shi HB, et al. Meta-analysis and GRADE evaluation of Tianmeng capsule(oral liquid)in the treatment of sleep disorders. Clin Res Pract. 2025;10(01):1-7. [In Chinese] doi: 10.19347/j.cnki.2096-1413.202501001
  14. Tong JY. Clinical observation of sweet dream oral liquid combined with Oxazepam in treating insomnia. China’s Naturop. 2019;27(17):72-74. [In Chinese] doi: 10.19621/j.cnki.11-3555/r.2019.1738
  15. Wang XY. Observation on the Therapeutic Effect of Tianmeng Oral Liquid in Patients with Insomnia. Chin J Mod Drug Appl. 2016;5:165-166. [In Chinese]. Available from: http://dianda.cqvip.com/Qikan/Article/Detail?id=667910667&from=Qikan_Article_Detail.
  16. Yao MM, Zhang YR. Efficacy and safety of Tianmeng oral liquid in the treatment of insomnia: a meta-analysis. Hainan Med J. 2021;32(21):2824-2830. [In Chinese]. Available from: https://oversea.cnki.net/kcms2/article/abstract?v= zO3wb1M9ekztpCgosv8OiQOsq9SZspuCKmx_5mDPsB_ CosIgk_ipbse6kDnuck3JA-R5hzpfeZfWlSmhrumBCs23u_ Vx3OL830sOv5PkTLTiyM3URcXapud0KEi5N4 KawarLxlnFKyFJ_Gld_x-ZqMcl4HwsR_b5QKw2IOco21D zpeRbo8HarQ==&uniplatform=OVERSEA.
  17. Yang S, Yu F, Xiang X, et al. Cost-effectiveness analysis of commercial Chinese polyherbal preparations for primary insomnia: based on network meta-analysis. Front Pharmacol. 2025;16:1682173. doi: 10.3389/fphar.2025.1682173
  18. Lin H, Yu ZF, Chen HH, et al. Clinical study on Tianmeng Oral Liquid in treatment of hyperprolactinemia caused by risperidone in female schizophrenia. Chin Tradit Herb Drugs. 2018;49(22):5373-5377. [In Chinese]. Available from: https:// oversea.cnki.net/kcms2/article/abstract?v=zO3wb1M9e kyvaEUTJsm5LBb6UD02tX-dCiHdiVPF9i69CXeAAk_ bJoB0UEHSnklKW133xIUGQb6HqSWgXhhMv skuDhFyavj_BQTybaOJsWg4O-BhNL1itIbSx69Ec3IKck 6RJMIJpgts0xAfMJiIF3SR_UhHUy0IRibOVyqOLGbPt_ z9MdRc_w==&uniplatform=OVERSEA.
  19. Jin FB, Hou RT, Li GF, et al. Clinical Observation of Tianmeng Oral Liquid in the Treatment of Diabetes with Comorbid Depression. Chin Tradit Herb Drugs. 2007;06:905-906. [In Chinese] doi: 10.3321/j.issn:0253-2670.2007.06.045
  20. Zhao J, Su MX, Fang QX. Clinical observation of Tianmeng Oral Liquid in treatment of chronic obstructive pulmonary disease and insomnia. Chin Tradit Herb Drugs. 2017;48(17): 3587-3589. [In Chinese]. https://oversea.cnki.net/kcms2/ article/abstract?v=zO3wb1M9ekweUhLFzty3GFQazC iqkGmYmYNG1wEM9W2DQiYgsZMSfKPCBUvrbr ZfFfQRxLgtEhWNmZqPo0Z3UYUkdumi2Q4OBc1vD_ MSVdBl9tIx6PZUfBCWcix-9EHt8priFS8eHy_4MfBYMW- 0 r i F T 4 5 q L DNEd 3 i O z - EeUQummv H J P x O - FXA==&uniplatform=OVERSEA.
  21. Luo JH, Li DG. Influence of sweet dream oral early intervention on depression and neurological rehabilitation after stroke. Chin Mod Med. 2014;21(03): 47-48. [In Chinese]. Available from: https://oversea.cnki.net/kcms2/ article/abstract?v=OGEEvuKkrhb2EFaL2kl8KhcF_Vww hAMBbFb44x4CgdtNZx8IJafQGbPlvZ7wyliwGf87Nt1 FFxILrAX38oJeghfkPpRc83vVdaSTQIjRQWyvBoJWvni V3kYfL1mZT_x5YgQUA0j9kfUcvOoR3NtAOmmCNBYB -cv9PGCmQur-YhLFgbRavno7Yw==&uniplatform=OVE RSEA&language=EN.
  22. Sun ML, Yang XC, Zhang SY, Zeng CY, Huang LX. Effect of Tianmeng Oral Liquid Combined with Zolpidem Tablets on Sleep Quality and Quality of Life in Patients with Gynecological Malignancies Undergoing Postoperative Chemotherapy. Strait Pharm J. 2020;32(11):148-150. [In Chinese]
  23. Bai R R. Clinical observation of Tianmeng Oral Solution combined with zopiclone in treatment of senile cor pulmonale insomnia. Drugs Clin. 2016;31(09):1468-1472. [In Chinese]. Available online: https://oversea.cnki.net/kcms2/article/ abstract?v=zO3wb1M9ekwyhzzyOBRZ3z5nLxs WBVLKbH1RnFlVA0LEnJtZlBALe9VhjO28NT8 9aQMF97hRkrC_Jmwzyw7FVpotFInaUYkCcg9iLkQk-r o orWBXUs BEDMFWd Tv j G k v YQy L q k E I R y a k a O u k 6 d N 0 ny V By Jp x F 4 9 t K Y s d r _ v D m _ ynBsSqZXD7dhQ==&uniplatform=OVERSEA.
  24. Gu JH, Zhang HM. Observation on the Curative Effect of Acupuncture on Sishengcong Combined with Tianmeng Oral Liquid in the Treatment of Senile Insomnia. World of Sleep Med. 2018;5(11):1296-1297. [In Chinese]. Available from: https://oversea.cnki.net/ kcms2/article/abstract?v=zO3wb1M9ekzmyulzVbQc_ H 1 3 B J m Q b E C s c x y N p b 1 c c i 3 5 w 7 V I R - YMm9bYk8UJGm-O1g2FdQnkm0esB2RLNB6dGDe-dhRwWgDlnvk1ZYrvtHH_PP-EhMvFX8568aL_uree-V692 ea8jXD9QJZBq05g2WEad8J0LTeIiojS48Hc3pP35ATTIYU dfw==&uniplatform=OVERSEA.
  25. Xiao D F. Clinical observation of Tianmeng Oral Liquid combined with eszopiclone in treatment of post-stroke insomnia. Drugs Clin. 2016;31(10):1612-5. [In Chinese]. Available from: https://oversea.cnki.net/kcms2/article/ abstract?v=zO3wb1M9ekwN-kWeaQywPgRCX2zRfiV86Y m_53UAl3KmqlgbDkcHf4PmkQM1uk4VN-n5V3z-NCH nFGnjTRL3XffKdNkdP2TJ0mlyUnEhrtBIske0fuXjQq7K TxJA8RdhO7Kfc9c4MfyR9nCVXjLyksUxPD5Smasi4sJ_ uCgBVW49NekxeXubcQ==&uniplatform=OVERSEA.
  26. Huang WZ, Xie TS, Luo ZD, et al. Clinical Efficacy of Eszopiclone Combined with Tianmeng Oral Liquid in Treating Sleep Disorders in Patients with Mild Stroke. J Qiqihar Med Univ. 2019;40(12):1471-1472. [In Chinese] doi: 10.3969/j.issn.1002-1256.2019.12.008
  27. Wang CY, Wang YJ, Zeng H, et al. Effects of flupentixol and melitracen tablets combined with Tianmeng Oral Liquid on sleep quality and negative emotions of insomnia patients with anxiety. J Clin Med Pract. 2020;24(09):33-36. [In Chinese]. Available from: https://oversea.cnki.net/kcms2/ article/abstract?v=zO3wb1M9ekyfSYDuDKZ_PNC5De2-- mDLY_Habfb-fI-GC8ew6XsiulOyq1lwHxE1mPSIDy-QFV KrzsQHwPY5FypWOKVLse1Hvo8LostOrahrCtyTUWhdy 5Xtn8jMKgOKSGfIm9U3uhxokiERJTkuSx7vg2OJz5sFdlA uiThuXdRVoP9p_-v0dQ==&uniplatform=OVERSEA.
  28. Wang ZY, Sun YZ, Shi YH, et al. Network Meta-analysis of Chinese patent medicine for post-stroke depression. Drug Eval Res. 2021;44(12):2664-2680. [In Chinese]. Available from: https://oversea.cnki.net/kcms2/article/ abstract?v=zO3wb1M9ekzSfBZ4_QD4Qd__cUBUbWQ__ HGuh5UMaJJ8vNrH80cFopzGEo-x7haH2qKMxD7sbVI WI6iYC85J4WXCbbMvRHQkaAjo2x7pn5KeUsIogSs6Z7Y rIekyDWJU-MIsuSGA1cAiqaMJk6kcE0qVijworQPv373gk XmlLyrN6mLhbOrBDg==&uniplatform=OVERSEA.
  29. Xia SB, Yu DH. Clinical Observation of Tianmeng Oral Liquid Combined with Paroxetine in the Treatment of Perimenopausal Depression. Chin Pharm. 2017;28(03):344- 347. [In Chinese]. Available from: https://oversea.cnki.net/ kcms2/article/abstract?v=zO3wb1M9ekzSfBZ4_QD4Qd__ cUBUbWQ__HGuh5UMaJJ8vNrH80cFopzGEo-x7h aH2qKMxD7sbVIWI6iYC85J4WXCbbMvRHQkaA jo2x7pn5KeUsIogSs6Z7YrIekyDWJU-MIsuSGA1cA iqaMJk6kcE0qVijworQPv373gkXmlLyrN6mLhbO­rBDg==&uniplatform=OVERSEA.
  30. Wang SX, Pang YC, Wang DK, et al. Clinical Observation of Tianmeng Oral Liquid Combined with Paroxetine in the Treatment of Post-Traumatic Depression. Chin Tradit Herb Drugs. 2006;08:1227-1228. [In Chinese] doi: 10.3321/j.issn:0253-2670.2006.08.045
  31. Wang Q, Bai LD, Zhang M, et al. Effect of Tianmeng oral liquid combined with atypical antipsychotic drugs on serum prolactin and sex hormone in patients with schizophrenia. Chin Med. 2018;13(06):870-874. [In Chinese]. Available from: https://oversea.cnki.net/kcms2/article/ abstract?v=zO3wb1M9ekyE41kGsz9cnx_BdGi_3rjPx98J1 NKQCPxghril0LQV5swRBPj-rDbHQ1lMt1PXoMVkW8- i3PBKFUSyuExY1hQi-QuKG9_C46Xcqn6wze2EZhmkxp 7tnOgSQNHN5zkKoQZ6vRS8bMiALIPfnP0GhSIOnSE-STq9-QAEx8V8CeBSAg==&uniplatform=OVERSEA.
  32. Lan XJ, Qin ZJ, Liu QM, et al. Efficacy and safety of Tianmeng Oral Liquid in the treatment of hyperprolactinemia caused by antipsychotics in female patients with schizophrenia: a Meta-analysis. Sichuan Ment Health. 2023;36(01):25-31. [In Chinese]. Available from: https://oversea.cnki.net/kcms2/ article/abstract?v=zO3wb1M9ekweFTFN0zB9HXcYHw JUckzzUy2AUc1sPfZbasGZvvJ7D7L4WM1yhRdyMC-fa87CoEkcZ1cgaIOyQDz9-kQcCNqeZhHQECel_fvd5XvF 2GXSPamsHGwwl2pObUyHNPFRddq14vlh-LKsxVFvwA ucVA16F8yqGi0D1z4WHzbrfo68Bg==&uniplatform=OV ERSEA.
  33. Liu J. Observation on the Efficacy of Tianmeng Oral Liquid in Regulating Autonomic Nervous System Imbalance. Chin Tradit Herb Drugs. 2010;41(07):1157-1158. [In Chinese]. Available from: https://d.wanfangdata.com.cn/periodical/ CiBQZXJpb2RpY2FsQ0hJU29scjkyMDI2MDMwNj E2NTI1NxIMemN5MjAxMDA3MDM1GghscTR2Zm s4MQ%3D%3D.
  34. Li CL, Xu Y, Jiang J, et al. Effects of Tianmeng Oral Liquid on Learning and Memory, Inflammatory Factors, and Neurotransmitters in Sleep-Deprived Rats. Pharmacol Clin Chin Mater Medica. 2015;31(02):147-148. (In Chinese). Available from: https://d.wanfangdata.com.cn/periodical/ CiBQZXJpb2RpY2FsQ0hJU29scjkyMDI2MDMwNjE 2NTI1Nx IQe n l 5 b H l s Y z IwMTUwMjA2NRo I MWwxdGZnMzI%3D.
  35. Su X, Wang C, Wang X, Han F, Lv C, Zhang X. Sweet Dream Liquid Chinese Medicine Ameliorates Learning and Memory Deficit in a Rat Model of Paradoxical Sleep Deprivation through the ERK/CREB Signaling Pathway. J Med Food. 2016;19(5):472-480. doi: 10.1089/jmf.2015.3530
  36. Liu K, Xia Q R, Liang J, et al. Effect and mechanism of Tianmeng oral liquid on glucose and lipid metabolism and endocrine disorders induced by risperidone. Cent South Pharm. 2024;22(11):2937-2942. [In Chinese]. Available from: https://oversea.cnki.net/kcms2/article/ abstract?v=zO3wb1M9ekwDTtbIihwziTZbkwzPDtUgOt X9OD5OwKl8Da25_1WpATzz0wDPeYgCAGNK_Q 8R812Gxzk1BlTHTBY8f2gG5irGGtJ2ZA8MrcNkfBF TTpRmwR_sidma_dre1AE0tHlvNXTUBG2J9Y81 iQEcAKptQTDWgwM02TwGBWjnV7S2FZEUI w==&uniplatform=OVERSEA.
  37. Han GJ. Study on the Improvement of Prolactin Levels and Cognitive Function in Schizophrenia Patients with Hyperprolactinemia by Different Treatments. 2024. [In Chinese] doi: 10.26921/d.cnki.ganyu.2024.000696
  38. Zhang YJ, Zhang J. Therapeutic effect of Tianmeng oral liquid combined with cystine tablet in the treatment of 52 cases of male-pattem alopecia. Clin Res Pract. 2018;3(22):138-140. doi: 10.19347/j.cnki.2096-1413.201822064 (In Chinese)
  39. Ding WT. Clinical Observation of Tianmeng Oral Liquid in the Treatment of Insomnia with Erectile Dysfunction. Chin Med Herald. 2007;20:106. [In Chinese] doi: 10.3969/j.issn.1673-7210.2007.20.081
  40. Zhang Y, Ji QL. Effect of sweet dream oral liquid combined with Doxepin in the treatment of palmoplantar eczema in patients with anxiety. Chin Pract Med. 2020;15(26):109-111. [In Chinese] doi: 10.14163/j.cnki.11-5547/r.2020.26.046
  41. Liu X, Zhang AJ, Yan ZR. Improvement of Post-Stroke Depression, Sleep, or Cognitive Dysfunction by Mindfulness Therapy Combined with Tianmeng Oral Liquid. Medical Diet and Health. 2020;18(04):55-56. [In Chinese]. Available from: https://d.wanfangdata.com.cn/periodical/ CiBQZXJpb2RpY2FsQ0hJU29scjkyMDI2MDMw NjE2NTI1NxIQeXhzbHlqa z IwMjAwNDAzORo Ia3J4eWx1dDg%3D.
  42. Wu D, Guo RJ, Wang Y. Clinical observation of Sweet Dream Oral Liquid curing deficiency of spleen and kidney style MCI. Chin Tradit Herb Drugs. 2017;48(23):4958-4962. [In Chinese]. Available from: https://oversea.cnki.net/kcms2/article/ abstract?v=zO3wb1M9ekySbio4UygghbmRHqV9tG_ BVonlGqhMCho4GStUTN1xaoTsMx-hZg64zxDOJB7y8cs CS59yIhIrP6fVvSFkPawZcJll85FfaG84EmvLvBeb79cNxtZe Jmbs_rBT6pHLl_MnsuJJ2Yq9JzifoOz9FyJyO-vGZoV8pUx XtaGDl6afsA==&uniplatform=OVERSEA.
  43. Dai BX, Yuan CR. Clinical Effective observation on Neurasthenia Treated by Tian Meng Oral Fluid. J Guiyang Univ Chin Med. 2003;(02):14-15. [In Chinese] doi: 10.3969/j.issn.1002-1108.2003.02.009
  44. Expert Group on Clinical Application of Tianmeng Oral Liquid (Capsules). Expert Recommendations on the Clinical Application of Tianmeng Oral Liquid (Capsules). J Psychiatry. 2019;32(4):294-298. [In Chinese] doi: 10.3969/j.issn.2095-9346.2019.04.015
  45. Shi J. Guidelines for Clinical Application of Chinese Patent Medicine in Treatment of Insomnia (2023). Chin J Integr Tradit West Med. 2025;1-8. [In Chinese]
  46. Alimoradi Z, Jafari E, Brostrom A, et al. Effects of cognitive behavioral therapy for insomnia (CBT-I) on quality of life: A systematic review and meta-analysis. Sleep Med Rev. 2022;64:101646. doi: 10.1016/j.smrv.2022.101646
  47. Wang JM, Nie CM, Zhang Y. Clinical Efficacy of Cognitive Behavior Therapy Plus Tianmeng Oral Liquid in Treatment of Insomnia. World J Sleep Med. 2020;7(03):441-443. [In Chinese]. Available from: https://oversea.cnki.net/kcms2/article/ abstract?v=zO3wb1M9ekwTlCOFCYNtCOxgC7VA1QDC zpoY5J36v0slZOwBJYDbEnSKORkBRLtxeLuIhEMm4smJ ququUdyJaQeAJk64FXlfFCl8bFhHoSZdYl2aGN1 lp6HfH1kY81LIdHVSyl-i_P3MBFi72KwUP3MxY MJ7czpUD8x9hRMJfOAYHg aj4WQYwQ==& uniplatform=OVERSEA.
  48. Li Z, Hao GJ, Li GY, et al. Observation on Curative Effect of Tianmeng Oral Liquid Combined with Psychotherapy on Insomnia. World J Sleep Med. 2018;5(04):433-435. [In Chinese]. Available from: https://oversea.cnki. net/kcms2/article/abstract?v=zO3wb1M9ekxk9q1Q ZoACL3xKGS07qshY79GO8Jdas1z4kvSTE83zaNZ AnVjJ1FGawWeLKcTx7PJXQN2DfSj5EgTSi7Q4mN zd7Rlu4H5Hi7-HDnBbi81xzhgd5Y1JuTmaVNoYiu­_ _ y _ 9 9 b R y 0 g 4 7 j 5 x s 6 g M L P p _ z _ K J KQ ztEDb7ZlgAOK8wsVFw==&uniplatform=OVERSEA.
  49. Gong YR, Tang L. Progress in physical therapy of sleep disorders. China Modern Medicine. 2023;30(10): 48-53. [In Chinese]. Available from: https:// oversea.cnki.net/kcms2/article/abstract?v=zO3w b1M9ekyK8JiwRZk0oy5tCsGa0acdZelt3QnwmlZ_PM3D Sy7lqOONutNazHkX0MNl8AMOe7IrUwmd5-lS3joloM6 dV144nsut2KKX91D8t0V4DHMkT1kP5ZahRM4seFyYO A5o8WAesDMRMMbEZjLMkmi1ufTYu1eJ8UsLpd6eS8 0Jh1-ORQ==&uniplatform=OVERSEA.
  50. Guo YX. Clinical Observation of Tianmeng Oral Liquid Combined with Repetitive Transcranial Magnetic Stimulation in Elderly Patients with Insomnia. Chin Naturop. 2018;26(03):51-53. [In Chinese] doi: 10.19621/j.cnki.11-3555/r.2018.0336
  51. Goessl VC, Curtiss JE, Hofmann SG. The effect of heart rate variability biofeedback training on stress and anxiety: a meta-analysis. Psychol Med. 2017;47(15):2578-2586. doi: 10.1017/S0033291717001003
  52. Lin IM, Fan SY, Yen CF, et al. Heart Rate Variability Biofeedback Increased Autonomic Activation and Improved Symptoms of Depression and Insomnia among Patients with Major Depression Disorder. Clin Psychopharmacol Neurosci. 2019; 17(2):222-232. doi: 10.9758/cpn.2019.17.2.222
Next article in this issue
Share
Back to top
Journal of Clinical and Basic Psychosomatics, Electronic ISSN: 2972-4414 Print ISSN: 3060-8562, Published by AccScience Publishing
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here
Accept